O6-alkylguanine-DNA alkyltransferase: Role in carcinogenesis and chemotherapy

BioEssays

Volumn 24, Issue 3, 2002, Pages 255-266

  Margison, Geoffrey P ^a   Santibáñez Koref, Mauro F ^b  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; CARCINOGEN; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE;

ANIMAL; BIOSYNTHESIS; CELL TRANSFORMATION; DNA REPAIR; ENZYMOLOGY; HUMAN; METABOLISM; NEOPLASM; PHYSIOLOGY; REVIEW;

ALKYLATING AGENTS; ANIMALS; CARCINOGENS; CELL TRANSFORMATION, NEOPLASTIC; DNA REPAIR; HUMANS; NEOPLASMS; O(6)-METHYLGUANINE-DNA METHYLTRANSFERASE;

EID: 0036006173     PISSN: 02659247     EISSN: None     Source Type: Journal    
DOI: 10.1002/bies.10063     Document Type: Review

References (79)

1. 6-methylguanine-DNA methyltransferase expression
2. 6-methylguanine and the cytotoxicity of methylating agents
3. 6-alkylguanine by alkyltransferases
4. DNA adducts: Endogenous and induced
5. Specific excision of methylation products from DNA of Escherichia coli treated with N-methyl-N'-nitro-N-nitrosoguanidine
6. Comparative studies of the hepatocarcinogen N N-dimethylnitrosamine in vivo: Reaction sites in rat liver DNA and the significance of their relative stabilities
7. 6-methylguanine from rat liver DNA
8. 6-alkylguanine-DNA alkyl-transferase
9. 6-benzylguanine
10. Engineering human DNA alkyltransferases for gene therapy using random sequence mutagenesis
11. 6-alkylguanine-DNA alkyltransferase
12. 6-benzylguanine or 1,3-bis(2-chloroethyl)-1-nitrosourea
13. 6-methylguanine-DNA methyltransferase are both required for its nuclear localization: The possible implications
14. 6-methylguanine lesion
15. 6-methylguanine, in transcribed genes prevents mutation of H-ras in rat mammary tumorigenesis induced by ethylnitrosourea in place of methylnitrosourea
16. 6-alkylguanine-DNA alkyltransferase in human brain tumor cells
17. 6-methylguanine-DNA methyltransferase and chloroethylnitrosourea-treated DNA
18. 6-methylguanine-DNA methyltransferase in a DNA excision repair-deficient Chinese hamster ovary cell line and its response to certain alkylating agents
19. 4MeT from nucleotide excision repair
20. 6-alkylguanine-DNA alkyltransferase
21. Sensitivity to DNA cross-linking chemotherapeutic agents in mismatch repair-defective cells in vitro and in xenografts
22. 6-alkylguanine DNA lesions trigger apoptosis
23. BASC a super complex of BRCA1-associated proteins involved in the recognition and repair of aberrant DNA structures
24. Alkylation-induced apoptosis of embryonic stem cells in which the gene for DNA-repair, methyltransferase, had been disrupted by gene targeting
25. A role for mismatch repair in production of chromosome aberrations by methylating agents in human cells
26. 6-methylguanine in Mex-, Mex+, and methylation-tolerant mismatch repair compromised cells: Facts and models
27. The role of DNA single- and double-strand breaks in cell killing by ionizing radiation
28. 6-methylguanine residues in genomic DNA and production of sister-chromatid exchanges, mutations and lethal events in a Mer-human tumor cell line
29. N-(2chloroethyl)-N'-cyclohexyl-N-nitrosourea sensitivity in mismatch repair-defective human cells
30. Bacterial and mammalian DNA alkyltransferases sensitize Escherichia coli to the lethal and mutagenic effects of dibromoalkanes
31. 6-methylguanine residues
32. Interaction of oligonucleotides containing 6-O-methyl-guanine with human DNA (cytosine-5-)-methyltransferase
33. 6-methylguanine inhibits the binding of transcription factors to DNA
34. 6-methylguanine in DNA inhibits replication in vitro by human cell extracts
35. 6-methylguanine
36. 6-methylguanine-DNA methyltransferase protects against nitrosamineinduced hepato Carcinogenesis
37. Increased susceptibility to chemotherapeutic alkylating agents of mice deficient in DNA repair methyltransferase
38. Separation of killing and tumorigenic effects of an alkylating agent in mice defective in two of the DNA repair genes
39. MutT-related error avoidance mechanism for DNA synthesis
40. 6-methyldeoxyguanosine monophosphate during in vitro DNA synthesis
41. 6-methylguanine-DNA methyltransferase in mammalian cells treated with N-methyl-N'-nitro-N-nitrosoguanidine
42. 6-alkylguanine-DNA alkyltransferase in cancer patients' lymphocytes
43. 6-alkylguanine-DNA-alkyltransferase in response to ionising radiation is p53 gene dose dependent
44. 6-methylguanine- DNA methyltransferase (MGMT) by DNA damaging agents
45. 6-methylguanine-DNA methyltransferase gene
46. 6-methylguanine-DNA methyltransferase gene by glucocorticoid hormone
47. 6-alkylguanine-DNA alkyltransferase in the rat liver
48. 6-methylguanine-DNA methyltransferase via protein kinase C-mediated signaling
49. 6-methylguanine-DNA methyltransferase gene by transcriptional coactivators cAMP response element-binding protein-binding protein and p300
50. 6-methylguanine-DNA methyltransferase expression during immortalization of cloned human fibroblasts
51. 6-methylguanine-DNA methyltransferase promoter region as a marker of gene silencing
52. 6-methylguanine DNA methyltransferase (MGMT) CpG island is associated with heterochromatinization of the MGMT transcription start site and silencing of the gene
53. Epigenetic regulation of the MGMT and hMSH6 DNA repair genes in cells resistant to methylating agents
54. Acquired resistance of melanoma cells to the antineoplastic agent fotemustine is caused by reactivation of the DNA repair gene MGMT
55. 6-methylguanine-DNA methyltransferase enhancer binding protein in DNA repair-deficient human cells
56. 6-methylguanine DNA methyltransferase gene is associated with the loss of nucleosome-like positioning
57. Nonenzymatic methylation of DNA by the intracellular methyl group donor S-adenosyl-L-methionine is a potentially mutagenic reaction
58. Nonenzymatic methylation of DNA by S-adenosylmethionine in vitro
59. 6-alkylguanine-DNA alkyltransferase deficient cells
60. Amino acid nitrosation products as alkylating agents
61. 6-methylguanine DNA methyltransferase-deficient yeast cells
62. A phylogenomic study of DNA repair genes, proteins, and processes
63. 6-methylguanine-DNA methyltransferase is associated with the presence of G:C to A:T transition mutations in p53 in human colorectal tumorigenesis
64. 6-substituted guanine-induced mutagenesis of ras oncogenes
65. N-nitroso-N-methylurea-induced rat mammary tumors arise from cells with preexisting oncogenic Hras1 gene mutations
66. Malignant transformation of human fibroblast cell strain MSU-1,1 by N-methyl-N-nitrosourea: Evidence of elimination of p53 by homologous recombination
67. Biochemical correlates of temozolomide sensitivity in pediatric solid tumor xenograft models
68. 6methylguanine-DNA methyltransferase activity and induction of novel immunogenicity in murine tumor cells treated with methylating agents
69. The toxicity of high dose BCNU with autologous bone marrow support
70. 6-methylguanine-DNA methyltransferase in pretreatment tumour biopsies as a predictor of response to temozolomide in melanoma
71. 6-alkylguanine DNA-alkyltransferase in human liver and melanoma
72. 6-methylguanine-DNA methyltransferase in human melanoma metastases
73. 6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia
74. 6-benzylguanine provides a means to evaluate the role of this protein in protection against carcinogenic and therapeutic alkylating agents
75. 6-(4-bromothenyl)guanine improves the therapeutic index of temozolomide against A375M melanoma xenografts
76. New cytotoxic agents for the treatment of metastatic malignant melanoma: Temozolomide and related alkylating agents in combination with guanine analogues to abrogate drug resistance
77. Gene transfer to suppress bone marrow alkylation sensitivity
78. 6-alkylguanine-DNA-alkyltransferase for engineering resistance of haemopoietic progenitor cells to multiple chemotherapeutic agents
79. Molecular epidemiology of therapy-related leukemias